Found: 28
Select item for more details and to access through your institution.
Associations between neuropsychiatric symptoms of affective and vegetative domains and brain morphology in aging people with mild cognitive impairment and Alzheimer's disease.
- Published in:
- International Journal of Geriatric Psychiatry, 2023, v. 38, n. 6, p. 1, doi. 10.1002/gps.5952
- By:
- Publication type:
- Article
Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer's disease.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-34129-4
- By:
- Publication type:
- Article
"Alzheimer's disease" is neither "Alzheimer's clinical syndrome" nor "dementia".
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, n. 1, p. 153, doi. 10.1016/j.jalz.2018.11.002
- By:
- Publication type:
- Article
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, n. 4, p. 535, doi. 10.1016/j.jalz.2018.02.018
- By:
- Publication type:
- Article
A Phase 1 First‐in‐Human Single‐Ascending‐Dose Trial With ESB1609, a Selective Agonist to the Sphingosine‐1‐Phosphate Receptor 5.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 6, p. 625, doi. 10.1002/cpdd.1256
- By:
- Publication type:
- Article
Sex Modulates the Pathological Aging Effect on Caudate Functional Connectivity in Mild Cognitive Impairment.
- Published in:
- Frontiers in Psychiatry, 2022, v. 13, p. 1, doi. 10.3389/fpsyt.2022.804168
- By:
- Publication type:
- Article
KL-VS heterozygosity is associated with lower amyloid-dependent tau accumulation and memory impairment in Alzheimer's disease.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-23755-z
- By:
- Publication type:
- Article
2017 NIA-AA RESEARCH FRAMEWORK TO INVESTIGATE THE ALZHEIMER’S DISEASE CONTINUUM.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P890, doi. 10.1016/j.jalz.2017.07.294
- By:
- Publication type:
- Article
POOLED AMYLOID PET BASELINE DATA FROM THE BAPINEUZUMAB IV PHASE III TRIALS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P614, doi. 10.1016/j.jalz.2016.06.1219
- By:
- Publication type:
- Article
Pooled biomarker analyses of phase 2 studies of vanutide cridificar vaccine (ACC-001) in mild-to-moderate and early Alzheimer’s disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P276, doi. 10.1016/j.jalz.2015.07.366
- By:
- Publication type:
- Article
The impact of reference region on the variance of estimated change in PET amyloid standard uptake value ratios measured longitudinally in summit and acction.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P547, doi. 10.1016/j.jalz.2015.06.696
- By:
- Publication type:
- Article
Perspective: The Alzheimer's Disease Neuroimaging Initiative and the role and contributions of the Private Partner Scientific Board (PPSB).
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. 840, doi. 10.1016/j.jalz.2015.04.001
- By:
- Publication type:
- Article
The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2013, v. 9, n. 5, p. e111, doi. 10.1016/j.jalz.2013.05.1769
- By:
- Publication type:
- Article
The Alzheimer’s Disease Neuroimaging Initiative: A review of papers published since its inception
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2012, v. 8, n. 1, p. S1, doi. 10.1016/j.jalz.2011.09.172
- By:
- Publication type:
- Article
Relationship between patient dependence on others and clinical measures of cognition, function and behavior in Alzheimer's disease (AD): Results from a longitudinal study
- Published in:
- 2011
- By:
- Publication type:
- Abstract
Immunotherapy with bapineuzumab lowers CSF tau protein levels in patients with Alzheimer's disease
- Published in:
- 2010
- By:
- Publication type:
- Abstract
Estimating dependence scale scores based on clinical dementia rating - sum of boxes scores in patients with mild cognitive impairment or mild to moderate Alzheimer's disease
- Published in:
- 2009
- By:
- Publication type:
- Abstract
Targeting Beta Amyloid: A Clinical Review of Immunotherapeutic Approaches in Alzheimer's Disease.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Targeting Beta Amyloid: A Clinical Review of Immunotherapeutic Approaches in Alzheimer's Disease.
- Published in:
- International Journal of Alzheimer's Disease, 2012, p. 1, doi. 10.1155/2012/628070
- By:
- Publication type:
- Article
Outcomes Assessment in Clinical Trials of Alzheimer's Disease and its Precursors: Readying for Short-term and Long-term Clinical Trial Needs.
- Published in:
- Innovations in Clinical Neuroscience, 2017, v. 14, n. 1/2, p. 22
- By:
- Publication type:
- Article
First-In-Human safety and long-term exposure data for AAB-003 (PF-05236812) and biomarkers after intravenous infusions of escalating doses in patients with mild to moderate Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2016, v. 8, p. 1, doi. 10.1186/s13195-016-0177-y
- By:
- Publication type:
- Article
Organ Biomarker Responses in Patients With Light Chain Amyloidosis Treated With NEOD001 Are Independent of Previous Hematologic Response.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e97, doi. 10.1016/j.clml.2017.03.175
- By:
- Publication type:
- Article
NEOD001 Demonstrates Organ Biomarker Responses in Patients With Light Chain Amyloidosis and Persistent Organ Dysfunction: Results From a Phase 1/2 Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e22, doi. 10.1016/j.clml.2017.03.038
- By:
- Publication type:
- Article
Differential Inhibition of LRRK2 in Parkinson's Disease Patient Blood by a G2019S Selective LRRK2 Inhibitor.
- Published in:
- Movement Disorders, 2021, v. 36, n. 6, p. 1362, doi. 10.1002/mds.28490
- By:
- Publication type:
- Article
Differential Inhibition of LRRK2 in Parkinson's Disease Patient Blood by a G2019S Selective LRRK2 Inhibitor.
- Published in:
- Movement Disorders, 2021, v. 36, n. 6, p. 1362, doi. 10.1002/mds.28490
- By:
- Publication type:
- Article
A data‐driven examination of apathy and depressive symptoms in dementia with independent replication.
- Published in:
- Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2023, v. 15, n. 1, p. 1, doi. 10.1002/dad2.12398
- By:
- Publication type:
- Article
Impact of amyloid and cardiometabolic risk factors on prognostic capacity of plasma neurofilament light chain for neurodegeneration.
- Published in:
- Alzheimer's Research & Therapy, 2024, v. 16, n. 1, p. 1, doi. 10.1186/s13195-024-01564-y
- By:
- Publication type:
- Article
Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers.
- Published in:
- Brain Imaging & Behavior, 2014, v. 8, n. 2, p. 183, doi. 10.1007/s11682-013-9262-z
- By:
- Publication type:
- Article